Nanomedicine, the therapeutic manipulation of biological processes on a molecular scale, is expected to have a significant impact on disease treatment as well as on the economy. Nanomedicine sales reached $16 billion in 2015, with over $3.8 billion in nanotechnology R&D invested each year. Evaluating the efficacy and toxicity of therapeutics on the nanometer scales inside of living cells is a major challenge for drug research and development as well as for scientists in academic research institutions. While technology exists to visualize biological dynamic processes at a resolution up to 10 nm, obtaining this technology can cost upwards of $500,000. We have developed a nanoscope at a cost of $35,000 without sacrificing resolution. Our miniSTORM paves the way for a new age of nanoscopy.